Cancer registries in Japan

National Clinical Database and site-specific cancer registries

Takayuki Anazawa, Hiroaki Miyata, Mitsukazu Gotoh

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The cancer registry is an essential part of any rational program of evidence-based cancer control. The cancer control program is required to strategize in a systematic and impartial manner and efficiently utilize limited resources. In Japan, the National Clinical Database (NCD) was launched in 2010. It is a nationwide prospective registry linked to various types of board certification systems regarding surgery. The NCD is a nationally validated database using web-based data collection software; it is risk adjusted and outcome based to improve the quality of surgical care. The NCD generalizes site-specific cancer registries by taking advantage of their excellent organizing ability. Some site-specific cancer registries, including pancreatic, breast, and liver cancer registries have already been combined with the NCD. Cooperation between the NCD and site-specific cancer registries can establish a valuable platform to develop a cancer care plan in Japan. Furthermore, the prognosis information of cancer patients arranged using population-based and hospital-based cancer registries can help in efficient data accumulation on the NCD. International collaboration between Japan and the USA has recently started and is expected to provide global benchmarking and to allow a valuable comparison of cancer treatment practices between countries using nationwide cancer registries in the future. Clinical research and evidence-based policy recommendation based on accurate data from the nationwide database may positively impact the public.

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalInternational Journal of Clinical Oncology
Volume20
Issue number1
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Registries
Japan
Databases
Neoplasms
Cancer Care Facilities
Benchmarking
Quality of Health Care
Certification
Liver Neoplasms
Pancreatic Neoplasms
Software
Breast Neoplasms
Research
Population

Keywords

  • Cancer registry
  • Nationwide database
  • Risk factor
  • Risk model

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Hematology
  • Medicine(all)

Cite this

Cancer registries in Japan : National Clinical Database and site-specific cancer registries. / Anazawa, Takayuki; Miyata, Hiroaki; Gotoh, Mitsukazu.

In: International Journal of Clinical Oncology, Vol. 20, No. 1, 2015, p. 5-10.

Research output: Contribution to journalReview article

@article{47747f31f2b44d12aedd15262a1fabce,
title = "Cancer registries in Japan: National Clinical Database and site-specific cancer registries",
abstract = "The cancer registry is an essential part of any rational program of evidence-based cancer control. The cancer control program is required to strategize in a systematic and impartial manner and efficiently utilize limited resources. In Japan, the National Clinical Database (NCD) was launched in 2010. It is a nationwide prospective registry linked to various types of board certification systems regarding surgery. The NCD is a nationally validated database using web-based data collection software; it is risk adjusted and outcome based to improve the quality of surgical care. The NCD generalizes site-specific cancer registries by taking advantage of their excellent organizing ability. Some site-specific cancer registries, including pancreatic, breast, and liver cancer registries have already been combined with the NCD. Cooperation between the NCD and site-specific cancer registries can establish a valuable platform to develop a cancer care plan in Japan. Furthermore, the prognosis information of cancer patients arranged using population-based and hospital-based cancer registries can help in efficient data accumulation on the NCD. International collaboration between Japan and the USA has recently started and is expected to provide global benchmarking and to allow a valuable comparison of cancer treatment practices between countries using nationwide cancer registries in the future. Clinical research and evidence-based policy recommendation based on accurate data from the nationwide database may positively impact the public.",
keywords = "Cancer registry, Nationwide database, Risk factor, Risk model",
author = "Takayuki Anazawa and Hiroaki Miyata and Mitsukazu Gotoh",
year = "2015",
doi = "10.1007/s10147-014-0757-4",
language = "English",
volume = "20",
pages = "5--10",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Cancer registries in Japan

T2 - National Clinical Database and site-specific cancer registries

AU - Anazawa, Takayuki

AU - Miyata, Hiroaki

AU - Gotoh, Mitsukazu

PY - 2015

Y1 - 2015

N2 - The cancer registry is an essential part of any rational program of evidence-based cancer control. The cancer control program is required to strategize in a systematic and impartial manner and efficiently utilize limited resources. In Japan, the National Clinical Database (NCD) was launched in 2010. It is a nationwide prospective registry linked to various types of board certification systems regarding surgery. The NCD is a nationally validated database using web-based data collection software; it is risk adjusted and outcome based to improve the quality of surgical care. The NCD generalizes site-specific cancer registries by taking advantage of their excellent organizing ability. Some site-specific cancer registries, including pancreatic, breast, and liver cancer registries have already been combined with the NCD. Cooperation between the NCD and site-specific cancer registries can establish a valuable platform to develop a cancer care plan in Japan. Furthermore, the prognosis information of cancer patients arranged using population-based and hospital-based cancer registries can help in efficient data accumulation on the NCD. International collaboration between Japan and the USA has recently started and is expected to provide global benchmarking and to allow a valuable comparison of cancer treatment practices between countries using nationwide cancer registries in the future. Clinical research and evidence-based policy recommendation based on accurate data from the nationwide database may positively impact the public.

AB - The cancer registry is an essential part of any rational program of evidence-based cancer control. The cancer control program is required to strategize in a systematic and impartial manner and efficiently utilize limited resources. In Japan, the National Clinical Database (NCD) was launched in 2010. It is a nationwide prospective registry linked to various types of board certification systems regarding surgery. The NCD is a nationally validated database using web-based data collection software; it is risk adjusted and outcome based to improve the quality of surgical care. The NCD generalizes site-specific cancer registries by taking advantage of their excellent organizing ability. Some site-specific cancer registries, including pancreatic, breast, and liver cancer registries have already been combined with the NCD. Cooperation between the NCD and site-specific cancer registries can establish a valuable platform to develop a cancer care plan in Japan. Furthermore, the prognosis information of cancer patients arranged using population-based and hospital-based cancer registries can help in efficient data accumulation on the NCD. International collaboration between Japan and the USA has recently started and is expected to provide global benchmarking and to allow a valuable comparison of cancer treatment practices between countries using nationwide cancer registries in the future. Clinical research and evidence-based policy recommendation based on accurate data from the nationwide database may positively impact the public.

KW - Cancer registry

KW - Nationwide database

KW - Risk factor

KW - Risk model

UR - http://www.scopus.com/inward/record.url?scp=84925515954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925515954&partnerID=8YFLogxK

U2 - 10.1007/s10147-014-0757-4

DO - 10.1007/s10147-014-0757-4

M3 - Review article

VL - 20

SP - 5

EP - 10

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 1

ER -